|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.34 USD | -0.25% |
|
-1.19% | -34.93% |
| Apr. 04 | North American Morning Briefing : Focus Turns to -2- | DJ |
| Apr. 03 | Citigroup Upgrades Integra LifeSciences to Neutral From Sell With $38 Price Target | MT |
Integra LifeSciences Holdings Corporation reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported sales was USD 397.04 million compared to USD 398.02 million a year ago. Net income was USD 19.83 million compared to USD 52.95 million a year ago.
Diluted earnings per share from continuing operations was USD 0.25 compared to USD 0.63 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -34.93% | 2.23B | |
| -2.31% | 187B | |
| -3.20% | 106B | |
| -5.04% | 66.9B | |
| +0.20% | 49.45B | |
| +17.29% | 48B | |
| +4.06% | 40.84B | |
| +2.36% | 26.25B | |
| +2.07% | 26.48B | |
| +12.96% | 24.62B |
INTEGRA LIFESCIENCES HOLDINGS CORPORATION 
